Amylyx Pharmaceuticals, Inc.
AMLX$14.29▲ 8.26% 24h
Amylyx Pharmaceuticals, Inc.AMLX$14.29
+$0.0662(+0.47%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.58B
P/E ratio
—
EPS (diluted)
$-1.53
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-144.74M
Net margin
—
Gross margin
—
Dividends & financials
Amylyx Pharmaceuticals, Inc. (AMLX) reported revenue of $0 and net income of $-144.74M, or $-1.53 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.